Orion Pharma Limited announcements
187 Dhaka Stock Exchange announcements for Orion Pharma Limited (ORIONPHARM) since 2013: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2014 (10).
- Q3 Earnings
(Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 30th September 2014 (July'14 to Sep'14), the Company has reported consolidated net profit after tax (excluding non-controlling interests) of Tk. 179.34 million with consolidated EPS of Tk. 0.77 as against Tk. 229.86 million and Tk. 0.98 respectively for the same period of the previous year. Whereas consolidated net profit after tax (excluding non-controlling interests) was Tk. 888.98 million with consolidated EPS of Tk. 3.80 for the period of nine months (Jan'14 to Sep'14) ended on 30.09.2014 as against Tk. 772.17 million and Tk. 3.30 respectively for the same period of the previous year.
- no undisclosed price sensitive information
In response to a CSE query dated September 18, 2014, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike.
- H/Y Earnings
(H/Y): As per un-audited half yearly accounts as on 30.06.2014 (Jan'14 to June'14), the Company has reported consolidated net profit after tax (excluding non-controlling interests) of Tk. 709.64 million with consolidated EPS of Tk. 3.03 as against Tk. 542.31 million and Tk. 2.32 respectively for the same period of the previous year. Whereas consolidated net profit after tax (excluding non-controlling interests) was Tk. 328.85 million with consolidated EPS of Tk. 1.40 for the period of 3 months (Apr'14 to June'14) ended on 30.06.2014 as against Tk. 248.14 million and Tk. 1.06 respectively for the same period of the previous year.
- Normal trading of the shares of the Company will resume on 22.05.2014 after record date.
Normal trading of the shares of the Company will resume on 22.05.2014 after record date.
- Trading of the shares of the Company will remain suspended on record date i.e., 21.05.2014.
Trading of the shares of the Company will remain suspended on record date i.e., 21.05.2014.
- Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be
Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle with cum benefit from 19.05.2014 to 20.05.2014. Trading of the shares of the Company will remain suspended on record date i.e., 21.05.2014.
- (Q1): As per un-audited quarterly accounts for the 1st quarter ended on 31st March 2014 (Jan'14 to March'14), the Compan
(Q1): As per un-audited quarterly accounts for the 1st quarter ended on 31st March 2014 (Jan'14 to March'14), the Company has reported consolidated net profit after tax (excluding non-controlling interest) of Tk. 380.79 million with consolidated EPS of Tk. 1.63 as against Tk. 294.17 million and Tk. 1.26 respectively for the same period of the previous year.
- The Board of Directors has recommended 15% cash dividend for the year ended on December 31, 2013. Date of AGM: 22.06.201
The Board of Directors has recommended 15% cash dividend for the year ended on December 31, 2013. Date of AGM: 22.06.2014, Time: 10:30 AM, Venue: Orion Pharma Plant, Shumilpara, Siddirgonj (South Adjacent of Adamjee EPZ), Narayongonj. Record Date: 21.05.2014. The Company has also reported consolidated EPS of Tk. 4.06, consolidated NAV per share of Tk. 65.23 and consolidated NOCFPS of Tk. 10.74 for the year ended on December 31, 2013.
- There will be no price limit on the trading of the shares of the Company today (11.05.2014) following its corporate decl
There will be no price limit on the trading of the shares of the Company today (11.05.2014) following its corporate declaration.
- As per Regulation 30 of DSE Listing Regulations, the Company has informed that a meeting of the Board of Directors will
As per Regulation 30 of DSE Listing Regulations, the Company has informed that a meeting of the Board of Directors will be held on May 10, 2014 at 5:00 PM to consider, among others, audited financial statements of the Company for the year ended on December 31, 2013.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.